CLINICAL_TRIALS
trial_result
· 2024-02-15
Clinical Trial Update: A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India [Phase 4]
Summary
Phase 4 clinical trial update for insulin glargine (LY2963016) in adults with type 2 diabetes in India; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2024-02-15